Position in ILMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$74,614,578
+$35,670,158 QoQ
Shares Held
605,343
+103.9% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Ilex Capital Partners (UK) LLP holds $338,382,479 across 5 Diagnostics & Research names. ILMN ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
1,206,449 | $137,511,057 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
605,343 | $74,614,578 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
276,395 | $47,136,403 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
92,014 | $45,227,641 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
196,480 | $33,892,800 |
All Filings in ILMN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,614,578 | 605,343 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,944,420 | 296,923 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $64,808,192 | 682,407 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,704,493 | 154,119 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,460,649 | 18,410 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||